CLINICAL TRIALS

BACKGROUND

U.S. service members, who often live and work in close quarters, have unique exposures and susceptibility to infectious diseases, which can decrease individual and unit readiness. The development of vaccines and therapeutics to protect against diseases that pose a threat to the health of service members would enhance operational readiness.

VALUE

By leveraging our surveillance network, the Infectious Diseases team can enhance force health protection by contributing to the development of vaccines and preventive measures through research and support for clinical trials.

GOALS

Conduct clinical trials in support of new vaccines and therapeutics
Provide vaccine effectiveness data to the Centers for Disease Control and Prevention (CDC) on annual influenza vaccines
Continue to assess vaccine safety, with an emphasis on military-specific vaccines
Inform policies regarding disease prevention and diagnosis through U.S. Food and Drug Administration (FDA) clinical trials

CAPABILITIES

CAP-accredited laboratory with culture and molecular techniques
High-throughput PCR testing for a wide variety of pathogens
Whole-genome sequencing analysis

RESEARCH

Phase IIb, double-blind, randomized trial to evaluate the efficacy and immunogenicity of norovirus vaccine
Evaluate longevity of functional anti-SARS-CoV-2 antibodies
Study early indicators of infection, prior to symptom onset, to limit spread of infection in populations such as the military

Bureau of Medicine and Surgery
7700 Arlington Blvd. Ste. 5113 Falls Church, VA 22042-5113
This is an official U.S. Navy website
This is a Department of Defense (DoD) Internet computer system.

General Navy Medical Inquiries (to Bureau of Medicine and Surgery): usn.ncr.bumedfchva.mbx.bumed-general-inquiries@health.mil